| MeSH term | MeSH ID | Detail |
|---|---|---|
| Uterine Cervical Erosion | D002579 | 2 associated lipids |
| Uterine Cervical Incompetence | D002581 | 3 associated lipids |
| Chancroid | D002602 | 4 associated lipids |
| Chlamydiaceae Infections | D002694 | 2 associated lipids |
| Choanal Atresia | D002754 | 1 associated lipids |
| Cholelithiasis | D002769 | 16 associated lipids |
| Cholestasis | D002779 | 23 associated lipids |
| Choline Deficiency | D002796 | 16 associated lipids |
| Chorioamnionitis | D002821 | 5 associated lipids |
| Choroiditis | D002833 | 1 associated lipids |
erythromycin
erythromycin is a lipid of Polyketides (PK) class. Erythromycin is associated with abnormalities such as Systemic Inflammatory Response Syndrome, Pneumonia, Infection, Pneumococcal Infections and Exanthema. The involved functions are known as Pharmacodynamics, Sterility, Agent, Drug Kinetics and Adjudication. Erythromycin often locates in Blood, peritoneal, Extracellular, Ribosomes and apicoplast. The associated genes with erythromycin are P4HTM gene, SLC33A1 gene, FAM3B gene, Operon and Homologous Gene. The related lipids are Hydroxytestosterones, Steroids, Propionate, Mycolic Acids and campesterol. The related experimental models are Mouse Model and Knock-out.
Cross Reference
Introduction
To understand associated biological information of erythromycin, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
What diseases are associated with erythromycin?
erythromycin is suspected in Pneumonia, Infection, Gonorrhea, Cystic Fibrosis, Respiratory Tract Infections, Influenza and other diseases in descending order of the highest number of associated sentences.
Related references are mostly published in these journals:
- Antimicrob. Agents Chemother. (35)
- J. Antimicrob. Chemother. (18)
- Clin. Infect. Dis. (2)
- Others (29)
| Disease | Cross reference | Weighted score | Related literature |
|---|
Loading... please refresh the page if content is not showing up.
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with erythromycin
PubChem Associated disorders and diseases
What pathways are associated with erythromycin
There are no associated biomedical information in the current reference collection.
PubChem Biomolecular Interactions and Pathways
Link to PubChem Biomolecular Interactions and PathwaysWhat cellular locations are associated with erythromycin?
Visualization in cellular structure
Associated locations are in red color. Not associated locations are in black.
Related references are published most in these journals:
- Antimicrob. Agents Chemother. (20)
- J. Antimicrob. Chemother. (9)
- Drug Metab. Dispos. (2)
- Others (20)
| Location | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What functions are associated with erythromycin?
Related references are published most in these journals:
| Function | Cross reference | Weighted score | Related literatures |
|---|
What lipids are associated with erythromycin?
Related references are published most in these journals:
| Lipid concept | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What genes are associated with erythromycin?
Related references are published most in these journals:
- Antimicrob. Agents Chemother. (19)
- J. Antimicrob. Chemother. (10)
- Drug Metab. Dispos. (5)
- Others (29)
| Gene | Cross reference | Weighted score | Related literatures |
|---|
What common seen animal models are associated with erythromycin?
Mouse Model
Mouse Model are used in the study 'In vitro and in vivo activities of macrolide derivatives against Mycobacterium tuberculosis.' (Falzari K et al., 2005) and Mouse Model are used in the study 'Activity of ABT-773 against Mycobacterium avium complex in the beige mouse model.' (Cynamon MH et al., 2000).
Knock-out
Knock-out are used in the study 'Functional expression and comparative characterization of nine murine cytochromes P450 by fluorescent inhibition screening.' (McLaughlin LA et al., 2008).
Related references are published most in these journals:
| Model | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
NCBI Entrez Crosslinks
All references with erythromycin
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| CRONK GA and NAUMANN DE | Ilotycin (erythromycin) for fusospirochetal infections of the oro-pharynx; a progress report. | 1953 | J Lancet | pmid:13221896 |
| AUSTRIAN R and ROSENBLUM R | The relative efficacy of erythromycin (ilotycin) and of penicillin in the treatment of pneumococcal lobar pneumonia. | 1953 | Am. J. Med. Sci. | pmid:13104398 |
| LIVINGOOD CS et al. | Erythromycin in local treatment of cutaneous bacterial infections. | 1953 | J Am Med Assoc | pmid:13108585 |
| RUIZ SANCHEZ F et al. | [Clinical experiences with carbomycin and erythromycin]. | 1953 | Medicina (Mex) | pmid:13110596 |
| SCHONBERG IL | The treatment of pyogenic skin infections with ilotycin ointment (erythromycin). | 1953 | Ohio Med | pmid:13111755 |
| MARTIN WJ et al. | The present status of erythromycin. | 1953 | Proc Staff Meet Mayo Clin | pmid:13112261 |
| PERLMAN D | Colorimetric method for determination of aureomycin, carbomycin, erythromycin, and terramycin in aqueous solution. | 1953 | Science | pmid:13113207 |
| TALLEY RW | Clinical evaluation of erythromycin. | 1953 | South. Med. J. | pmid:13113414 |
| HEDENIUS P and TUNEVALL HG | [Erythromycin, its antibacterial effect in vitro, its absorption and excretion, with a preliminary report on a series of cases with erythromycin therapy]. | 1953 | Sven Lakartidn | pmid:13113605 |
| KIRBY WM et al. | Erythromycin serum concentrations following administration in acid-resistant tablets. | 1953 | Antibiot Chemother (Northfield) | pmid:24542409 |
| KIRSHBAUM A et al. | A cupplate method for the determination of erythromycin concentrations in serum and other body fluids. | 1953 | Antibiot Chemother (Northfield) | pmid:24542421 |
| CLARK RK | The chemistry of erythromycin. I. Acid degradation products. | 1953 | Antibiot Chemother (Northfield) | pmid:24542535 |
| MAPLE FM et al. | Serum concentrations of erythromycin following intravenous administration. | 1953 | Antibiot Chemother (Northfield) | pmid:24542586 |
| LEE CC et al. | Tissue distribution of erythromycin in rats. | 1953 | Antibiot Chemother (Northfield) | pmid:24542649 |
| SYLVESTER JC and JOSSELYN LE | Absorption of erythromycin. II. Erythromycin stearate. | 1953 | Antibiot Chemother (Northfield) | pmid:24542651 |
| BACON AE | Erythromycin in the treatment of pneumococcal pneumonia. | 1953 | Del Med J | pmid:13094978 |
| GRIGSBY ME et al. | Some laboratory and clinical experiences with erythromycin. | 1953 | Antibiot Chemother (Northfield) | pmid:24542704 |
| RUIZ SANCHEZ F et al. | [Erythromycin in the treatment of diarrheas due to Micrococcus pyogenes]. | 1953 | Medicina (Mex) | pmid:13098728 |
| HASBROUCK RB and GARVEN FC | The chemistry of erythromycin. II. Acid degradation products. | 1953 | Antibiot Chemother (Northfield) | pmid:24542706 |
| DORE R | [Basal metabolism; significance and interpretation]. | 1953 | Union Med Can | pmid:13122881 |
| DEARING WH | Micrococcic (staphylococcic) enteritis as a complication of antibiotic therapy; its response to erythromycin. | 1953 | Proc Staff Meet Mayo Clin | pmid:13037897 |
| NEW antibiotic. | 1953 | South. Med. J. | pmid:13038549 | |
| FREEMAN LC and SCOTT RB | Erythromycin in treatment of pyoderma in children. | 1953 | J. Pediatr. | pmid:13053367 |
| NESERKE EI | Clinical report on the new antibiotic, erythromycin. | 1953 | J. Am. Vet. Med. Assoc. | pmid:13061363 |
| GABLE GR et al. | Treatment of gonorrhea with erythromycin. | 1953 | Am J Syph Gonorrhea Vener Dis | pmid:13065617 |
| HERRELL WE et al. | Erythromycin for infections due to Micrococcus pyogenes. | 1953 | J Am Med Assoc | pmid:13069224 |
| ROBINSON HM and ZELIGMAN I | Erythromycin ointment in the treatment of the pyodermas. | 1953 | J. Invest. Dermatol. | pmid:13069824 |
| ROBINSON HM and COHEN MM | Treatment of granuloma inguinale with erythromycin. | 1953 | J. Invest. Dermatol. | pmid:13069825 |
| BAZAN C et al. | [Treatment of whooping cough with erythromycin]. | 1953 | Rev Chil Pediatr | pmid:13134787 |
| BRICAIRE H and DE FOSSEY B | [Two new antibiotics: erythromycin and soframycin]. | 1953 | Rev Prat | pmid:13135190 |
| LUND E | [Erythromycin, a new antibiotic]. | 1953 | Ugeskr. Laeg. | pmid:13136562 |
| HINSHAW HC | The treatment of infectious diseases: advances in the use of antimicrobial drugs. | 1953 | Calif Med | pmid:13094538 |
| MCCOWEN MC et al. | The effects of erythromycin (ilotycin, lilly) against certain parasitic organisms. | 1953 | Am. J. Trop. Med. Hyg. | pmid:13040654 |
| LUND E | Erythromycin; a new antibiotic. | 1953 | Acta Pathol Microbiol Scand | pmid:13138191 |
| DE GENNES L et al. | [Erythromycin treatment of four infections]. | 1953 Apr 17-24 | Bull Mem Soc Med Hop Paris | pmid:13066998 |
| RAVINA A et al. | [Some observations on erythromycin treatment]. | 1953 May 15-22 | Bull Mem Soc Med Hop Paris | pmid:13067012 |
| [Erythromycin (ilotycin)]. | 1953 May 2-9 | Clin Nuova Rass Prog Med Int | pmid:13116428 | |
| PANNARALE MR | [Effect of erythromycin on the epithelial inclusions (Halbertstaedter and Prowazek bodies) of the trachomatous conjunctiva]. | 1953 Sep-Nov | Boll. Soc. Ital. Biol. Sper. | pmid:13140753 |
| ROCCHIETTA S | [The recent French studies on erythromycin]. | 1954 | Boll Chim Farm | pmid:13182015 |
| LEON AP | [Ilotycin in therapy of diphtheria and of carriers of Corynebacterium diphtheriae]. | 1954 | Rev Inst Salubr Enferm Trop | pmid:13225071 |
| LEON AP and CANO C | [Effect of ilotycin on Brucella and its use with streptomycin in therapy of human brucellosis]. | 1954 | Rev Inst Salubr Enferm Trop | pmid:13225072 |
| HERRELL WE | Current therapeutics; erythromycin. | 1954 | Practitioner | pmid:13145442 |
| COHEN WB | The uses of erythromycin in dermatology. | 1954 | R I Med J | pmid:13145972 |
| HAIGHT TH et al. | Erythromycin therapy of respiratory infections. II. Effects of varying durations of therapy of streptococcal infections on eradication of streptococci and on formation of antistreptolysin O. | 1954 | Antibiot Chemother (Northfield) | pmid:24543018 |
| LAING CR and SCOTT RB | Erythromycin-polymyxin ointment in the treatment of pyoderma in children. | 1954 | Antibiot Chemother (Northfield) | pmid:24543095 |
| WADDINGTON WS et al. | Treatment of bacterial pneumonia with erythromycin. | 1954 | AMA Arch Intern Med | pmid:13137631 |
| ALEXANDER LJ and SCHOCH AG | Erythromycin in venereal diseases. | 1954 | Am J Syph Gonorrhea Vener Dis | pmid:13138815 |
| MANNING PR et al. | Erythromycin in the treatment of gonorrhea. | 1954 | Am J Syph Gonorrhea Vener Dis | pmid:13138816 |
| ANDERSON HH et al. | Antibiotic synergism in amebiasis. | 1954 | Am. J. Trop. Med. Hyg. | pmid:13138827 |
| BASTIN R et al. | [Not Available]. | 1954 | Actual Biol | pmid:14398500 |